nodes	percent_of_prediction	percent_of_DWPC	metapath
Imipramine—CHRM3—nephrolithiasis	0.711	1	CbGaD
Imipramine—Conduction disorder—Hydrochlorothiazide—nephrolithiasis	0.00961	0.105	CcSEcCtD
Imipramine—CHRM3—ureter—nephrolithiasis	0.00943	0.156	CbGeAlD
Imipramine—SLC22A2—nephron—nephrolithiasis	0.00652	0.108	CbGeAlD
Imipramine—Sleep disturbance—Hydrochlorothiazide—nephrolithiasis	0.00359	0.0392	CcSEcCtD
Imipramine—CYP2C19—urine—nephrolithiasis	0.00285	0.0471	CbGeAlD
Imipramine—Ventricular arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.00272	0.0297	CcSEcCtD
Imipramine—Ventricular fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00263	0.0287	CcSEcCtD
Imipramine—Numbness—Hydrochlorothiazide—nephrolithiasis	0.00243	0.0265	CcSEcCtD
Imipramine—CYP1A2—urine—nephrolithiasis	0.00233	0.0384	CbGeAlD
Imipramine—Sensory loss—Hydrochlorothiazide—nephrolithiasis	0.00232	0.0254	CcSEcCtD
Imipramine—CYP2E1—urine—nephrolithiasis	0.00209	0.0346	CbGeAlD
Imipramine—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.00205	0.0224	CcSEcCtD
Imipramine—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00201	0.022	CcSEcCtD
Imipramine—HTR2A—urine—nephrolithiasis	0.00182	0.0301	CbGeAlD
Imipramine—KCND3—cortex of kidney—nephrolithiasis	0.00169	0.028	CbGeAlD
Imipramine—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.00169	0.0184	CcSEcCtD
Imipramine—CYP3A4—urine—nephrolithiasis	0.00168	0.0278	CbGeAlD
Imipramine—CYP2D6—urine—nephrolithiasis	0.00166	0.0274	CbGeAlD
Imipramine—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.00163	0.0179	CcSEcCtD
Imipramine—Libido decreased—Hydrochlorothiazide—nephrolithiasis	0.00158	0.0172	CcSEcCtD
Imipramine—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.00156	0.0171	CcSEcCtD
Imipramine—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.00155	0.0169	CcSEcCtD
Imipramine—Purpura—Hydrochlorothiazide—nephrolithiasis	0.00152	0.0166	CcSEcCtD
Imipramine—CYP3A7-CYP3A51P—nephron tubule—nephrolithiasis	0.00146	0.0241	CbGeAlD
Imipramine—Disturbance in sexual arousal—Hydrochlorothiazide—nephrolithiasis	0.00145	0.0158	CcSEcCtD
Imipramine—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.00144	0.0157	CcSEcCtD
Imipramine—SLC22A2—nephron tubule—nephrolithiasis	0.00141	0.0233	CbGeAlD
Imipramine—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.00138	0.0151	CcSEcCtD
Imipramine—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.00137	0.015	CcSEcCtD
Imipramine—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.00135	0.0147	CcSEcCtD
Imipramine—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.00134	0.0146	CcSEcCtD
Imipramine—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.00132	0.0144	CcSEcCtD
Imipramine—SLC22A2—renal system—nephrolithiasis	0.00128	0.0211	CbGeAlD
Imipramine—CYP3A7-CYP3A51P—cortex of kidney—nephrolithiasis	0.00125	0.0206	CbGeAlD
Imipramine—SLC22A2—kidney—nephrolithiasis	0.00124	0.0204	CbGeAlD
Imipramine—ADRA1B—renal system—nephrolithiasis	0.00122	0.0202	CbGeAlD
Imipramine—SLC22A2—cortex of kidney—nephrolithiasis	0.0012	0.0199	CbGeAlD
Imipramine—ADRA1B—kidney—nephrolithiasis	0.00118	0.0196	CbGeAlD
Imipramine—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00117	0.0127	CcSEcCtD
Imipramine—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00116	0.0127	CcSEcCtD
Imipramine—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00115	0.0126	CcSEcCtD
Imipramine—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00115	0.0126	CcSEcCtD
Imipramine—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00111	0.0121	CcSEcCtD
Imipramine—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.0011	0.0121	CcSEcCtD
Imipramine—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.0011	0.0121	CcSEcCtD
Imipramine—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.0011	0.012	CcSEcCtD
Imipramine—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00105	0.0115	CcSEcCtD
Imipramine—SLC22A4—nephron tubule—nephrolithiasis	0.00104	0.0173	CbGeAlD
Imipramine—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00101	0.011	CcSEcCtD
Imipramine—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00101	0.011	CcSEcCtD
Imipramine—Maprotiline—CHRM3—nephrolithiasis	0.000973	0.198	CrCbGaD
Imipramine—SLC22A4—renal system—nephrolithiasis	0.000949	0.0157	CbGeAlD
Imipramine—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.000943	0.0103	CcSEcCtD
Imipramine—Flushing—Hydrochlorothiazide—nephrolithiasis	0.000939	0.0103	CcSEcCtD
Imipramine—SLC22A4—kidney—nephrolithiasis	0.000918	0.0152	CbGeAlD
Imipramine—SLC22A1—renal system—nephrolithiasis	0.000904	0.0149	CbGeAlD
Imipramine—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.000903	0.00987	CcSEcCtD
Imipramine—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.000894	0.00976	CcSEcCtD
Imipramine—SLC22A4—cortex of kidney—nephrolithiasis	0.000894	0.0148	CbGeAlD
Imipramine—SLC22A1—kidney—nephrolithiasis	0.000874	0.0144	CbGeAlD
Imipramine—Tension—Hydrochlorothiazide—nephrolithiasis	0.000864	0.00944	CcSEcCtD
Imipramine—SLC22A3—renal system—nephrolithiasis	0.000864	0.0143	CbGeAlD
Imipramine—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.000862	0.00942	CcSEcCtD
Imipramine—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.000855	0.00934	CcSEcCtD
Imipramine—SLC22A3—kidney—nephrolithiasis	0.000835	0.0138	CbGeAlD
Imipramine—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00083	0.00906	CcSEcCtD
Imipramine—Tremor—Hydrochlorothiazide—nephrolithiasis	0.000825	0.00901	CcSEcCtD
Imipramine—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.000817	0.00892	CcSEcCtD
Imipramine—Agitation—Hydrochlorothiazide—nephrolithiasis	0.000809	0.00884	CcSEcCtD
Imipramine—Malaise—Hydrochlorothiazide—nephrolithiasis	0.000794	0.00867	CcSEcCtD
Imipramine—Syncope—Hydrochlorothiazide—nephrolithiasis	0.000789	0.00862	CcSEcCtD
Imipramine—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.000788	0.00861	CcSEcCtD
Imipramine—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.000778	0.0085	CcSEcCtD
Imipramine—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.000774	0.00845	CcSEcCtD
Imipramine—CHRM3—renal system—nephrolithiasis	0.000749	0.0124	CbGeAlD
Imipramine—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.000747	0.00816	CcSEcCtD
Imipramine—HTR1A—renal system—nephrolithiasis	0.000746	0.0123	CbGeAlD
Imipramine—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00074	0.00809	CcSEcCtD
Imipramine—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.000733	0.00801	CcSEcCtD
Imipramine—CHRM3—kidney—nephrolithiasis	0.000725	0.012	CbGeAlD
Imipramine—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.000724	0.00791	CcSEcCtD
Imipramine—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.000718	0.00785	CcSEcCtD
Imipramine—Oedema—Hydrochlorothiazide—nephrolithiasis	0.000718	0.00785	CcSEcCtD
Imipramine—HTR7—renal system—nephrolithiasis	0.000713	0.0118	CbGeAlD
Imipramine—Shock—Hydrochlorothiazide—nephrolithiasis	0.000707	0.00772	CcSEcCtD
Imipramine—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.000703	0.00768	CcSEcCtD
Imipramine—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.000701	0.00766	CcSEcCtD
Imipramine—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.000695	0.00759	CcSEcCtD
Imipramine—HTR7—kidney—nephrolithiasis	0.00069	0.0114	CbGeAlD
Imipramine—ADRA1A—renal system—nephrolithiasis	0.000688	0.0114	CbGeAlD
Imipramine—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.000685	0.00748	CcSEcCtD
Imipramine—KCNH2—renal system—nephrolithiasis	0.000665	0.011	CbGeAlD
Imipramine—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00065	0.0071	CcSEcCtD
Imipramine—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.000645	0.00705	CcSEcCtD
Imipramine—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.000639	0.00698	CcSEcCtD
Imipramine—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.000632	0.00691	CcSEcCtD
Imipramine—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.000625	0.00682	CcSEcCtD
Imipramine—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.000619	0.00677	CcSEcCtD
Imipramine—Constipation—Hydrochlorothiazide—nephrolithiasis	0.000614	0.00671	CcSEcCtD
Imipramine—CYP2B6—nephron tubule—nephrolithiasis	0.0006	0.00992	CbGeAlD
Imipramine—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.000592	0.00647	CcSEcCtD
Imipramine—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.000588	0.00642	CcSEcCtD
Imipramine—Nortriptyline—CHRM3—nephrolithiasis	0.000585	0.119	CrCbGaD
Imipramine—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.000571	0.00623	CcSEcCtD
Imipramine—CYP1A2—renal system—nephrolithiasis	0.000569	0.0094	CbGeAlD
Imipramine—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.000568	0.0062	CcSEcCtD
Imipramine—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.000568	0.0062	CcSEcCtD
Imipramine—CYP2E1—nephron tubule—nephrolithiasis	0.000563	0.00931	CbGeAlD
Imipramine—CYP2B6—renal system—nephrolithiasis	0.000545	0.00901	CbGeAlD
Imipramine—Methotrimeprazine—CHRM3—nephrolithiasis	0.000538	0.109	CrCbGaD
Imipramine—Promethazine—CHRM3—nephrolithiasis	0.00053	0.108	CrCbGaD
Imipramine—CYP2B6—kidney—nephrolithiasis	0.000527	0.00871	CbGeAlD
Imipramine—Doxepin—CHRM3—nephrolithiasis	0.000525	0.107	CrCbGaD
Imipramine—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.000515	0.00563	CcSEcCtD
Imipramine—CYP2E1—renal system—nephrolithiasis	0.000512	0.00846	CbGeAlD
Imipramine—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.000508	0.00555	CcSEcCtD
Imipramine—CYP2E1—kidney—nephrolithiasis	0.000495	0.00818	CbGeAlD
Imipramine—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.000492	0.00537	CcSEcCtD
Imipramine—CYP2E1—cortex of kidney—nephrolithiasis	0.000482	0.00796	CbGeAlD
Imipramine—Desipramine—CHRM3—nephrolithiasis	0.000481	0.098	CrCbGaD
Imipramine—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.000475	0.00519	CcSEcCtD
Imipramine—Promazine—CHRM3—nephrolithiasis	0.000466	0.0949	CrCbGaD
Imipramine—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.000457	0.00499	CcSEcCtD
Imipramine—Rash—Hydrochlorothiazide—nephrolithiasis	0.000453	0.00495	CcSEcCtD
Imipramine—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.000453	0.00494	CcSEcCtD
Imipramine—Headache—Hydrochlorothiazide—nephrolithiasis	0.00045	0.00492	CcSEcCtD
Imipramine—HTR2A—renal system—nephrolithiasis	0.000445	0.00735	CbGeAlD
Imipramine—HTR2A—kidney—nephrolithiasis	0.00043	0.00711	CbGeAlD
Imipramine—Nausea—Hydrochlorothiazide—nephrolithiasis	0.000427	0.00466	CcSEcCtD
Imipramine—CYP3A4—renal system—nephrolithiasis	0.000412	0.00681	CbGeAlD
Imipramine—Chlorpromazine—CHRM3—nephrolithiasis	0.00041	0.0835	CrCbGaD
Imipramine—Amitriptyline—CHRM3—nephrolithiasis	0.000406	0.0826	CrCbGaD
Imipramine—CYP2D6—renal system—nephrolithiasis	0.000405	0.0067	CbGeAlD
Imipramine—CYP3A4—kidney—nephrolithiasis	0.000398	0.00658	CbGeAlD
Imipramine—CYP2D6—kidney—nephrolithiasis	0.000392	0.00648	CbGeAlD
Imipramine—ABCB1—nephron tubule—nephrolithiasis	0.000321	0.0053	CbGeAlD
Imipramine—ABCB1—renal system—nephrolithiasis	0.000292	0.00482	CbGeAlD
Imipramine—ABCB1—kidney—nephrolithiasis	0.000282	0.00466	CbGeAlD
Imipramine—ABCB1—cortex of kidney—nephrolithiasis	0.000274	0.00454	CbGeAlD
Imipramine—CHRM2—GPCR ligand binding—PTH—nephrolithiasis	7.38e-05	0.000557	CbGpPWpGaD
Imipramine—ADRA1A—GPCR ligand binding—PTH—nephrolithiasis	7.36e-05	0.000556	CbGpPWpGaD
Imipramine—HTR6—GPCR downstream signaling—CHRM3—nephrolithiasis	7.26e-05	0.000548	CbGpPWpGaD
Imipramine—HTR7—GPCR downstream signaling—CHRM3—nephrolithiasis	7.25e-05	0.000548	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—RGS14—nephrolithiasis	7.21e-05	0.000544	CbGpPWpGaD
Imipramine—ADRA1B—GPCR downstream signaling—DGKH—nephrolithiasis	7.08e-05	0.000535	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—GRHPR—nephrolithiasis	7.04e-05	0.000531	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—GRHPR—nephrolithiasis	7.02e-05	0.00053	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—ADCY10—nephrolithiasis	6.94e-05	0.000524	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—ADCY10—nephrolithiasis	6.91e-05	0.000522	CbGpPWpGaD
Imipramine—CHRM4—GPCR downstream signaling—CHRM3—nephrolithiasis	6.85e-05	0.000517	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—RGS14—nephrolithiasis	6.77e-05	0.000512	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—DGKH—nephrolithiasis	6.75e-05	0.00051	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—DGKH—nephrolithiasis	6.72e-05	0.000507	CbGpPWpGaD
Imipramine—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	6.68e-05	0.000504	CbGpPWpGaD
Imipramine—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	6.68e-05	0.000504	CbGpPWpGaD
Imipramine—HTR6—GPCR downstream signaling—PTH—nephrolithiasis	6.64e-05	0.000502	CbGpPWpGaD
Imipramine—HTR7—GPCR downstream signaling—PTH—nephrolithiasis	6.63e-05	0.000501	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—ADCY10—nephrolithiasis	6.61e-05	0.000499	CbGpPWpGaD
Imipramine—HTR6—Signaling by GPCR—CHRM3—nephrolithiasis	6.59e-05	0.000498	CbGpPWpGaD
Imipramine—HTR7—Signaling by GPCR—CHRM3—nephrolithiasis	6.59e-05	0.000497	CbGpPWpGaD
Imipramine—CHRM5—GPCR downstream signaling—CHRM3—nephrolithiasis	6.56e-05	0.000495	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—GRHPR—nephrolithiasis	6.55e-05	0.000494	CbGpPWpGaD
Imipramine—DRD2—GPCR downstream signaling—DGKH—nephrolithiasis	6.53e-05	0.000493	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—DGKH—nephrolithiasis	6.43e-05	0.000486	CbGpPWpGaD
Imipramine—HTR2A—GPCR downstream signaling—DGKH—nephrolithiasis	6.42e-05	0.000485	CbGpPWpGaD
Imipramine—HRH1—GPCR downstream signaling—DGKH—nephrolithiasis	6.41e-05	0.000484	CbGpPWpGaD
Imipramine—CHRM1—GPCR downstream signaling—DGKH—nephrolithiasis	6.39e-05	0.000482	CbGpPWpGaD
Imipramine—CHRM3—GPCR downstream signaling—DGKH—nephrolithiasis	6.37e-05	0.000481	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—DGKH—nephrolithiasis	6.31e-05	0.000476	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—DGKH—nephrolithiasis	6.29e-05	0.000475	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—AGXT—nephrolithiasis	6.27e-05	0.000474	CbGpPWpGaD
Imipramine—CHRM4—GPCR downstream signaling—PTH—nephrolithiasis	6.27e-05	0.000473	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—AGXT—nephrolithiasis	6.26e-05	0.000473	CbGpPWpGaD
Imipramine—CHRM4—Signaling by GPCR—CHRM3—nephrolithiasis	6.22e-05	0.00047	CbGpPWpGaD
Imipramine—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	6.21e-05	0.000469	CbGpPWpGaD
Imipramine—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	6.21e-05	0.000469	CbGpPWpGaD
Imipramine—ADRA1D—GPCR downstream signaling—CHRM3—nephrolithiasis	6.17e-05	0.000466	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—ADCY10—nephrolithiasis	6.1e-05	0.00046	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—GRHPR—nephrolithiasis	6.05e-05	0.000457	CbGpPWpGaD
Imipramine—SLC22A3—Metabolism—AQP1—nephrolithiasis	6.05e-05	0.000457	CbGpPWpGaD
Imipramine—HTR6—Signaling by GPCR—PTH—nephrolithiasis	6.03e-05	0.000455	CbGpPWpGaD
Imipramine—HTR7—Signaling by GPCR—PTH—nephrolithiasis	6.02e-05	0.000455	CbGpPWpGaD
Imipramine—CHRM5—GPCR downstream signaling—PTH—nephrolithiasis	6e-05	0.000453	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—ADCY10—nephrolithiasis	6e-05	0.000453	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—ADCY10—nephrolithiasis	5.99e-05	0.000452	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—ADCY10—nephrolithiasis	5.97e-05	0.000451	CbGpPWpGaD
Imipramine—CHRM5—Signaling by GPCR—CHRM3—nephrolithiasis	5.96e-05	0.00045	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—ADCY10—nephrolithiasis	5.95e-05	0.000449	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—DGKH—nephrolithiasis	5.93e-05	0.000448	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—RGS14—nephrolithiasis	5.9e-05	0.000446	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—ADCY10—nephrolithiasis	5.89e-05	0.000445	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—ADCY10—nephrolithiasis	5.87e-05	0.000444	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—RGS14—nephrolithiasis	5.87e-05	0.000444	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—AGXT—nephrolithiasis	5.84e-05	0.000441	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—DGKH—nephrolithiasis	5.83e-05	0.00044	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—DGKH—nephrolithiasis	5.82e-05	0.000439	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—DGKH—nephrolithiasis	5.8e-05	0.000438	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—DGKH—nephrolithiasis	5.78e-05	0.000437	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—DGKH—nephrolithiasis	5.73e-05	0.000432	CbGpPWpGaD
Imipramine—CYP2C18—Metabolism—AQP1—nephrolithiasis	5.72e-05	0.000432	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—DGKH—nephrolithiasis	5.71e-05	0.000431	CbGpPWpGaD
Imipramine—CHRM4—Signaling by GPCR—PTH—nephrolithiasis	5.69e-05	0.00043	CbGpPWpGaD
Imipramine—ADRA1D—GPCR downstream signaling—PTH—nephrolithiasis	5.64e-05	0.000426	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—RGS14—nephrolithiasis	5.62e-05	0.000425	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—CHRM3—nephrolithiasis	5.6e-05	0.000423	CbGpPWpGaD
Imipramine—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	5.53e-05	0.000418	CbGpPWpGaD
Imipramine—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	5.53e-05	0.000418	CbGpPWpGaD
Imipramine—SLC22A3—Metabolism—CHRM3—nephrolithiasis	5.47e-05	0.000413	CbGpPWpGaD
Imipramine—CHRM5—Signaling by GPCR—PTH—nephrolithiasis	5.45e-05	0.000411	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—AGXT—nephrolithiasis	5.39e-05	0.000407	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—ATP6V0A4—nephrolithiasis	5.39e-05	0.000407	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—DGKH—nephrolithiasis	5.39e-05	0.000407	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—ATP6V0A4—nephrolithiasis	5.38e-05	0.000406	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—DGKH—nephrolithiasis	5.38e-05	0.000406	CbGpPWpGaD
Imipramine—HTR1A—GPCR downstream signaling—CHRM3—nephrolithiasis	5.38e-05	0.000406	CbGpPWpGaD
Imipramine—HTR2C—GPCR downstream signaling—CHRM3—nephrolithiasis	5.35e-05	0.000404	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—APRT—nephrolithiasis	5.33e-05	0.000403	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—SLC26A1—nephrolithiasis	5.33e-05	0.000403	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—SLC26A1—nephrolithiasis	5.32e-05	0.000402	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—APRT—nephrolithiasis	5.32e-05	0.000402	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—GRHPR—nephrolithiasis	5.2e-05	0.000393	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—RGS14—nephrolithiasis	5.18e-05	0.000391	CbGpPWpGaD
Imipramine—CYP2C18—Metabolism—CHRM3—nephrolithiasis	5.17e-05	0.00039	CbGpPWpGaD
Imipramine—ADRA1D—Signaling by GPCR—PTH—nephrolithiasis	5.12e-05	0.000387	CbGpPWpGaD
Imipramine—ADRA1B—GPCR downstream signaling—CHRM3—nephrolithiasis	5.12e-05	0.000387	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—RGS14—nephrolithiasis	5.1e-05	0.000385	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—GRHPR—nephrolithiasis	5.1e-05	0.000385	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—RGS14—nephrolithiasis	5.09e-05	0.000384	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—DGKH—nephrolithiasis	5.08e-05	0.000384	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—ATP6V0A4—nephrolithiasis	5.08e-05	0.000384	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—RGS14—nephrolithiasis	5.07e-05	0.000383	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—RGS14—nephrolithiasis	5.06e-05	0.000382	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—RGS14—nephrolithiasis	5.01e-05	0.000378	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—RGS14—nephrolithiasis	4.99e-05	0.000377	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—APRT—nephrolithiasis	4.96e-05	0.000375	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—SLC26A1—nephrolithiasis	4.96e-05	0.000375	CbGpPWpGaD
Imipramine—HTR1A—GPCR downstream signaling—PTH—nephrolithiasis	4.92e-05	0.000371	CbGpPWpGaD
Imipramine—HTR2C—GPCR downstream signaling—PTH—nephrolithiasis	4.89e-05	0.000369	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—CHRM3—nephrolithiasis	4.88e-05	0.000369	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—ATP6V0A4—nephrolithiasis	4.87e-05	0.000368	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—DGKH—nephrolithiasis	4.87e-05	0.000368	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—CHRM3—nephrolithiasis	4.86e-05	0.000367	CbGpPWpGaD
Imipramine—DRD2—GPCR downstream signaling—CHRM3—nephrolithiasis	4.72e-05	0.000356	CbGpPWpGaD
Imipramine—ADRA1B—GPCR downstream signaling—PTH—nephrolithiasis	4.68e-05	0.000354	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—CHRM3—nephrolithiasis	4.65e-05	0.000351	CbGpPWpGaD
Imipramine—HTR2A—GPCR downstream signaling—CHRM3—nephrolithiasis	4.64e-05	0.000351	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—AGXT—nephrolithiasis	4.64e-05	0.00035	CbGpPWpGaD
Imipramine—HRH1—GPCR downstream signaling—CHRM3—nephrolithiasis	4.63e-05	0.00035	CbGpPWpGaD
Imipramine—CHRM1—GPCR downstream signaling—CHRM3—nephrolithiasis	4.62e-05	0.000349	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—SLC26A1—nephrolithiasis	4.58e-05	0.000346	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—APRT—nephrolithiasis	4.58e-05	0.000346	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—DGKH—nephrolithiasis	4.58e-05	0.000346	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—ATP6V0A4—nephrolithiasis	4.58e-05	0.000346	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—CHRM3—nephrolithiasis	4.56e-05	0.000344	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—CHRM3—nephrolithiasis	4.55e-05	0.000343	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—AGXT—nephrolithiasis	4.54e-05	0.000343	CbGpPWpGaD
Imipramine—HTR1A—Signaling by GPCR—PTH—nephrolithiasis	4.46e-05	0.000337	CbGpPWpGaD
Imipramine—HTR2C—Signaling by GPCR—PTH—nephrolithiasis	4.44e-05	0.000335	CbGpPWpGaD
Imipramine—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	4.42e-05	0.000334	CbGpPWpGaD
Imipramine—DRD2—GPCR downstream signaling—PTH—nephrolithiasis	4.32e-05	0.000326	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—CHRM3—nephrolithiasis	4.29e-05	0.000324	CbGpPWpGaD
Imipramine—ADRA1B—Signaling by GPCR—PTH—nephrolithiasis	4.25e-05	0.000321	CbGpPWpGaD
Imipramine—HTR2A—GPCR downstream signaling—PTH—nephrolithiasis	4.25e-05	0.000321	CbGpPWpGaD
Imipramine—HRH1—GPCR downstream signaling—PTH—nephrolithiasis	4.24e-05	0.00032	CbGpPWpGaD
Imipramine—CHRM1—GPCR downstream signaling—PTH—nephrolithiasis	4.22e-05	0.000319	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—CHRM3—nephrolithiasis	4.22e-05	0.000318	CbGpPWpGaD
Imipramine—CHRM3—GPCR downstream signaling—PTH—nephrolithiasis	4.21e-05	0.000318	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—CHRM3—nephrolithiasis	4.21e-05	0.000318	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—CHRM3—nephrolithiasis	4.19e-05	0.000317	CbGpPWpGaD
Imipramine—CHRM2—GPCR downstream signaling—PTH—nephrolithiasis	4.17e-05	0.000315	CbGpPWpGaD
Imipramine—ADRA1A—GPCR downstream signaling—PTH—nephrolithiasis	4.16e-05	0.000314	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—CHRM3—nephrolithiasis	4.14e-05	0.000313	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—CHRM3—nephrolithiasis	4.13e-05	0.000312	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	3.99e-05	0.000301	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—DGKH—nephrolithiasis	3.99e-05	0.000301	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—ATP6V0A4—nephrolithiasis	3.97e-05	0.0003	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—DGKH—nephrolithiasis	3.97e-05	0.0003	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—APRT—nephrolithiasis	3.94e-05	0.000298	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—SLC26A1—nephrolithiasis	3.94e-05	0.000298	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—GRHPR—nephrolithiasis	3.93e-05	0.000297	CbGpPWpGaD
Imipramine—DRD2—Signaling by GPCR—PTH—nephrolithiasis	3.92e-05	0.000296	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—CHRM3—nephrolithiasis	3.9e-05	0.000294	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—CHRM3—nephrolithiasis	3.89e-05	0.000294	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—SLC26A1—nephrolithiasis	3.86e-05	0.000292	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—APRT—nephrolithiasis	3.86e-05	0.000292	CbGpPWpGaD
Imipramine—HTR2A—Signaling by GPCR—PTH—nephrolithiasis	3.86e-05	0.000291	CbGpPWpGaD
Imipramine—HRH1—Signaling by GPCR—PTH—nephrolithiasis	3.85e-05	0.000291	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—GRHPR—nephrolithiasis	3.84e-05	0.00029	CbGpPWpGaD
Imipramine—CHRM1—Signaling by GPCR—PTH—nephrolithiasis	3.84e-05	0.00029	CbGpPWpGaD
Imipramine—CHRM3—Signaling by GPCR—PTH—nephrolithiasis	3.82e-05	0.000289	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—AQP1—nephrolithiasis	3.8e-05	0.000287	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—DGKH—nephrolithiasis	3.8e-05	0.000287	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—ATP6V0A4—nephrolithiasis	3.8e-05	0.000287	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—AQP1—nephrolithiasis	3.79e-05	0.000286	CbGpPWpGaD
Imipramine—CHRM2—Signaling by GPCR—PTH—nephrolithiasis	3.79e-05	0.000286	CbGpPWpGaD
Imipramine—ADRA1A—Signaling by GPCR—PTH—nephrolithiasis	3.78e-05	0.000285	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—CHRM3—nephrolithiasis	3.67e-05	0.000277	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—GRHPR—nephrolithiasis	3.62e-05	0.000273	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—PTH—nephrolithiasis	3.56e-05	0.000269	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—PTH—nephrolithiasis	3.56e-05	0.000269	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—AQP1—nephrolithiasis	3.54e-05	0.000267	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—CHRM3—nephrolithiasis	3.52e-05	0.000266	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—AGXT—nephrolithiasis	3.5e-05	0.000265	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—ATP6V0A4—nephrolithiasis	3.5e-05	0.000264	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—DGKH—nephrolithiasis	3.5e-05	0.000264	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—ATP6V0A4—nephrolithiasis	3.45e-05	0.00026	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—DGKH—nephrolithiasis	3.45e-05	0.00026	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—DGKH—nephrolithiasis	3.44e-05	0.00026	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—ATP6V0A4—nephrolithiasis	3.44e-05	0.00026	CbGpPWpGaD
Imipramine—CYP3A7—Metabolism—CHRM3—nephrolithiasis	3.44e-05	0.000259	CbGpPWpGaD
Imipramine—SLC22A2—Metabolism—CHRM3—nephrolithiasis	3.43e-05	0.000259	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—DGKH—nephrolithiasis	3.43e-05	0.000259	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—ATP6V0A4—nephrolithiasis	3.43e-05	0.000259	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—AGXT—nephrolithiasis	3.42e-05	0.000258	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—ATP6V0A4—nephrolithiasis	3.42e-05	0.000258	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—DGKH—nephrolithiasis	3.42e-05	0.000258	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—ATP6V0A4—nephrolithiasis	3.38e-05	0.000255	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—DGKH—nephrolithiasis	3.38e-05	0.000255	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—DGKH—nephrolithiasis	3.37e-05	0.000255	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	3.37e-05	0.000255	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—PTH—nephrolithiasis	3.36e-05	0.000254	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—CHRM3—nephrolithiasis	3.31e-05	0.00025	CbGpPWpGaD
Imipramine—CHRM3—Metabolism—AQP1—nephrolithiasis	3.27e-05	0.000247	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—AGXT—nephrolithiasis	3.22e-05	0.000243	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—PTH—nephrolithiasis	3.22e-05	0.000243	CbGpPWpGaD
Imipramine—SLC22A1—Metabolism—CHRM3—nephrolithiasis	3.2e-05	0.000241	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—GRHPR—nephrolithiasis	3.06e-05	0.000231	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—PTH—nephrolithiasis	3.03e-05	0.000229	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—SLC26A1—nephrolithiasis	2.98e-05	0.000225	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—APRT—nephrolithiasis	2.98e-05	0.000225	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—SLC26A1—nephrolithiasis	2.91e-05	0.00022	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—APRT—nephrolithiasis	2.91e-05	0.00022	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—CHRM3—nephrolithiasis	2.88e-05	0.000218	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—CHRM3—nephrolithiasis	2.87e-05	0.000217	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—AQP1—nephrolithiasis	2.81e-05	0.000212	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—AQP1—nephrolithiasis	2.75e-05	0.000208	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—CHRM3—nephrolithiasis	2.75e-05	0.000207	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	2.74e-05	0.000207	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—APRT—nephrolithiasis	2.74e-05	0.000207	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—AGXT—nephrolithiasis	2.73e-05	0.000206	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—PTH—nephrolithiasis	2.64e-05	0.000199	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—PTH—nephrolithiasis	2.62e-05	0.000198	CbGpPWpGaD
Imipramine—CYP2B6—Metabolism—CHRM3—nephrolithiasis	2.54e-05	0.000192	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—CHRM3—nephrolithiasis	2.53e-05	0.000191	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—PTH—nephrolithiasis	2.51e-05	0.00019	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—CHRM3—nephrolithiasis	2.49e-05	0.000188	CbGpPWpGaD
Imipramine—CYP2E1—Metabolism—CHRM3—nephrolithiasis	2.49e-05	0.000188	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—CHRM3—nephrolithiasis	2.49e-05	0.000188	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—CHRM3—nephrolithiasis	2.48e-05	0.000187	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—CHRM3—nephrolithiasis	2.45e-05	0.000185	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—CHRM3—nephrolithiasis	2.44e-05	0.000184	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—GRHPR—nephrolithiasis	2.36e-05	0.000179	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—SLC26A1—nephrolithiasis	2.32e-05	0.000175	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—APRT—nephrolithiasis	2.32e-05	0.000175	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—PTH—nephrolithiasis	2.32e-05	0.000175	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—PTH—nephrolithiasis	2.28e-05	0.000172	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—PTH—nephrolithiasis	2.27e-05	0.000172	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—PTH—nephrolithiasis	2.27e-05	0.000171	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—PTH—nephrolithiasis	2.26e-05	0.000171	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—PTH—nephrolithiasis	2.24e-05	0.000169	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—PTH—nephrolithiasis	2.23e-05	0.000168	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—AQP1—nephrolithiasis	2.12e-05	0.00016	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—AGXT—nephrolithiasis	2.11e-05	0.000159	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—AQP1—nephrolithiasis	2.07e-05	0.000156	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—AQP1—nephrolithiasis	1.95e-05	0.000147	CbGpPWpGaD
Imipramine—CYP2C19—Metabolism—CHRM3—nephrolithiasis	1.92e-05	0.000145	CbGpPWpGaD
Imipramine—ABCB1—Metabolism—CHRM3—nephrolithiasis	1.87e-05	0.000142	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	1.79e-05	0.000135	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—APRT—nephrolithiasis	1.79e-05	0.000135	CbGpPWpGaD
Imipramine—HTR6—Signaling Pathways—SPP1—nephrolithiasis	1.79e-05	0.000135	CbGpPWpGaD
Imipramine—HTR7—Signaling Pathways—SPP1—nephrolithiasis	1.79e-05	0.000135	CbGpPWpGaD
Imipramine—CYP2D6—Metabolism—CHRM3—nephrolithiasis	1.77e-05	0.000133	CbGpPWpGaD
Imipramine—CHRM4—Signaling Pathways—SPP1—nephrolithiasis	1.69e-05	0.000127	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—AQP1—nephrolithiasis	1.65e-05	0.000125	CbGpPWpGaD
Imipramine—CHRM5—Signaling Pathways—SPP1—nephrolithiasis	1.62e-05	0.000122	CbGpPWpGaD
Imipramine—ADRA1D—Signaling Pathways—SPP1—nephrolithiasis	1.52e-05	0.000115	CbGpPWpGaD
Imipramine—CYP1A2—Metabolism—CHRM3—nephrolithiasis	1.5e-05	0.000113	CbGpPWpGaD
Imipramine—HTR1A—Signaling Pathways—SPP1—nephrolithiasis	1.32e-05	0.0001	CbGpPWpGaD
Imipramine—HTR2C—Signaling Pathways—SPP1—nephrolithiasis	1.32e-05	9.95e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—AQP1—nephrolithiasis	1.28e-05	9.64e-05	CbGpPWpGaD
Imipramine—ADRA1B—Signaling Pathways—SPP1—nephrolithiasis	1.26e-05	9.52e-05	CbGpPWpGaD
Imipramine—DRD2—Signaling Pathways—SPP1—nephrolithiasis	1.16e-05	8.78e-05	CbGpPWpGaD
Imipramine—CYP3A4—Metabolism—CHRM3—nephrolithiasis	1.15e-05	8.72e-05	CbGpPWpGaD
Imipramine—HTR2A—Signaling Pathways—SPP1—nephrolithiasis	1.14e-05	8.64e-05	CbGpPWpGaD
Imipramine—HRH1—Signaling Pathways—SPP1—nephrolithiasis	1.14e-05	8.62e-05	CbGpPWpGaD
Imipramine—CHRM1—Signaling Pathways—SPP1—nephrolithiasis	1.14e-05	8.59e-05	CbGpPWpGaD
Imipramine—CHRM3—Signaling Pathways—SPP1—nephrolithiasis	1.13e-05	8.56e-05	CbGpPWpGaD
Imipramine—CHRM2—Signaling Pathways—SPP1—nephrolithiasis	1.12e-05	8.48e-05	CbGpPWpGaD
Imipramine—ADRA1A—Signaling Pathways—SPP1—nephrolithiasis	1.12e-05	8.46e-05	CbGpPWpGaD
